Chinese english Germany Japanese Korea

13-bromo-4-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-9-oxa-3,6-diazatricyclo[8.4.0.02,6]tetradeca1(14),2,4,10,12-pentaene

13-bromo-4-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-9-oxa-3,6-diazatricyclo[8.4.0.02,6]tetradeca1(14),2,4,10,12-pentaene Struktur
1282512-39-3
CAS-Nr.
1282512-39-3
Englisch Name:
13-bromo-4-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-9-oxa-3,6-diazatricyclo[8.4.0.02,6]tetradeca1(14),2,4,10,12-pentaene
Synonyma:
Imidazo[1,2-d][1,4]benzoxazepine, 10-bromo-5,6-dihydro-2-[1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]-;13-bromo-4-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-9-oxa-3,6-diazatricyclo[8.4.0.02,6]tetradeca1(14),2,4,10,12-pentaene
CBNumber:
CB73380762
Summenformel:
C16H16BrN5O
Molgewicht:
374.24
MOL-Datei:
1282512-39-3.mol
Request For Quotation

13-bromo-4-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-9-oxa-3,6-diazatricyclo[8.4.0.02,6]tetradeca1(14),2,4,10,12-pentaene Eigenschaften

Siedepunkt:
598.5±60.0 °C(Predicted)
Dichte
1.63±0.1 g/cm3(Predicted)
pka
3.18±0.20(Predicted)

Sicherheit

13-bromo-4-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-9-oxa-3,6-diazatricyclo[8.4.0.02,6]tetradeca1(14),2,4,10,12-pentaene Chemische Eigenschaften,Einsatz,Produktion Methoden

13-bromo-4-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-9-oxa-3,6-diazatricyclo[8.4.0.02,6]tetradeca1(14),2,4,10,12-pentaene Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

13-bromo-4-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-9-oxa-3,6-diazatricyclo[8.4.0.02,6]tetradeca1(14),2,4,10,12-pentaene Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Nanjing crow LuNing pharmaceutical technology co., LTD 13382066392
CHINA 4877 58
  • 13-bromo-4-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-9-oxa-3,6-diazatricyclo[8.4.0.02,6]tetradeca1(14),2,4,10,12-pentaene
  • Imidazo[1,2-d][1,4]benzoxazepine, 10-bromo-5,6-dihydro-2-[1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]-
  • 1282512-39-3
Copyright 2019 © ChemicalBook. All rights reserved